“We are pleased to recognize Dr. Andrew Chang as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
December 10, 2019

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Andrew Chang, MD, Chesapeake Urology in Brandywine, MD, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Chang has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Andrew Chang as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long-term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

l-r: Smile Brands Inc. Chief Legal Officer Victoria Harvey, CEO Steven C. Bilt and Chief Dental Officer Dr. Robert Crim

IRVINE, Calif (PRWEB)
December 10, 2019

Smile Brands Inc., one of the largest Dental Support Organizations in the U.S., was recently awarded the 2019 Communitas Award for their Excellence in Skills-Based Community Service. The award honors Smile Brands employees’ commitment to community service and global social responsibility. This is the second year in a row that Smile Brands has been honored with a Communitas Award for Excellence.

Smile Brands partners with the Smiles for Everyone Foundation to give back to local communities through pro-bono dental work. The Smiles for Everyone Foundation is a 501(c)(3) nonprofit that shares Smile Brands’ mission of delivering Smiles for Everyone®, by providing free dental care to those in need both at home in the U.S. and around the world. Over 1000 Smile Brands team members have volunteered at the Foundation-sponsored events in 2019.

Since 2011, Smile Brands affiliated volunteers have delivered over 26,000 smiles and provided $19 million in donated dentistry both domestically and abroad. The Foundation sponsors Community Smile Projects, including one-day free clinics in Smile Brands affiliated locations and Smile Makeovers, which are full mouth restorations for needy patients. They also sponsor International Smile Projects with outposts in Cambodia, Ghana, Laos, Nicaragua, Paraguay and Thailand. In 2019 the Foundation also launched a new program, called Implanting Inspiration, which provides free dental implants to select individuals in need.

About Smile Brands Inc.

Based in Irvine California, Smile Brands Inc. is one of the largest providers of support services to dental groups in the United States. The culture-driven organization is the #1 ranked multi-location healthcare provider on Glassdoor’s 2019 Best Places to Work list. Smile Brands provides comprehensive business support services through exclusive long-term agreements with affiliate dental groups, so dentists can spend more time caring for their patients and less time on the administrative, marketing, and financial aspects of operating a dental practice. Smile Brands supports 440 Bright Now!® Dental, Monarch Dental®, Castle Dental®, A+ Dental Care, OneSmile Dental, Johnson Family Dental, P3 Dental Group, and DecisionOne Dental Partners offices in 18 states, including Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Maryland, Ohio, Oregon, Nevada, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington and Wisconsin. Smile Brands is a portfolio company of Gryphon Investors, a leading middle-market private equity firm based in San Francisco, CA. For more information, visit http://www.smilebrands.com.

About the Smiles For Everyone Foundation

The Smiles for Everyone Foundation is a 501(c)(3) nonprofit organization with the mission of delivering smiles for everyone by providing free dental care for those in need, both at home in the U.S. and around the world. Since 2011, the Smiles for Everyone Foundation has delivered over 26,000 smiles and $19 million in donated dentistry. The foundation currently supports programs which provide free dental care to those in need in Cambodia, Ghana, Laos, Nicaragua, Paraguay, Thailand, and the United States. For more information or to make a donation, visit http://www.smilesforeveryone.org.

About the Communitas Awards

The Communitas Awards is an international effort to recognize the spirit of communitas- people helping people. Communitas winners unselfishly give of themselves and their resources, and are changing the way they do business to benefit their communities.

Communitas winners are recognized for specific programs involving volunteerism, philanthropy or ethical, sustainable business practices. Some businesses, organizations and individuals are also recognized as Leadership winners because of their excellence in multiple programs. A complete list of winners can be found on the Communitas website at http://www.communitasawards.com.

Contacts:

Smile Brands Inc.

Jody Martin    

PR@smilebrands.com                            

714.427.1299    

Communitas Awards

Ed Dalheim

info@communitasawards.com

214.377.3526

Share article on social media or email:

NPI/Florida’s Space Coast Office of Tourism

“This is a festive, fun in the sun family event. Whether you’re big into surfing or just looking to make more unforgettable holiday memories, Surfing Santas should be at the top of your holiday bucket list.”

COCOA BEACH, Fla. (PRWEB)
December 09, 2019

Cocoa Beach is preparing to host its 10th annual “Surfing Santas” event, an all-comers extravaganza that has become one of the world’s most-dazzling Santa-themed gatherings.

What began as a simple family beach day a decade ago has grown into the nation’s most beloved – and slightly zany – holiday tradition. Now, ten years in, there’s no better place for Santa to loosen up as he gets ready for his one annual workday than the surfing capital of the East Coast.

Last year, with a massive beachside crowd of more than 10,000 cheering them on, nearly 600 surfers took to the Atlantic all decked out in their best St. Nick outfits. This Christmas Eve morning, the infamous group of Surfing Santas are ready to hit the beach again with hopes of breaking their own record for the number of Santa Clauses simultaneously riding the waves.

“Surfing Santas is truly a sight to behold,” said event organizer George Trosset, who got the craze rolling somewhat innocently on Dec. 24, 2009, when a news photographer captured him wearing a Santa getup while surfing with his family. “Watching this explode into one of the largest and most-talked about holiday events has been nothing short of phenomenal.”

There are no skill or age requirements to participate as a Surfing Santa and the event is free. Just don your most-festive holiday garb and grab a board. Spectators are invited to dress up as well – cash prizes are in store for the best themed costumes, and one “people’s choice” grand prize winner in the costume contest will take home a Surfing Santas surfboard.

“This is a festive, fun in the sun family event. Whether you’re big into surfing or just looking to make more unforgettable holiday memories, Surfing Santas should be at the top of your holiday bucket list,” said Peter Cranis, the executive director of Florida’s Space Coast Office of Tourism. “For our guests from out of town, it’s a great opportunity to get into the holiday spirit while soaking up our Florida sunshine and unbeatable, laid-back Space Coast vibe.”

Since 2013, Surfing Santas has raised more than $130,000 for charity, through donations and sales of official Surfing Santas T-shirts. All proceeds benefit the work of two local organizations: the Grind for Life cancer support group and the 20-year-old Florida Surf Museum.

For more information about Surfing Santas and where to stay along the Space Coast, visit http://www.visitspacecoast.com. The Dec. 24 event will begin at 8 a.m. along the beach near 2 Minutemen Causeway (where the causeway intersects with Route A1A N. Atlantic Avenue) and is expected to continue until noon. Plenty of parking is available and numerous area restaurants will be open to serve Surfing Santa participants and spectators.

Share article on social media or email:

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, and Provo College.

Through the Boise and Idaho Falls campuses, Unitek seeks to promote student excellence, strengthen support for workforce development, and help fill the need for health care professionals in the United States.

NEWPORT BEACH, Calif. (PRWEB)
December 10, 2019

Unitek Learning is proud to announce the expansion of Eagle Gate College to Boise and Idaho Falls. Eagle Gate plans to offer medical assisting and nursing programs at both locations. The Idaho Board of Nursing recently gave Unitek initial approval to create nursing education programs for these new campuses. Based in California, Unitek seeks to provide Idaho residents with accelerated and convenient courses for their health care needs. The two campuses will open in 2020, and they will offer aspiring professionals a range of programs in the nursing field.

“During the Idaho Board of Nursing meeting that was held on October 10th in Boise, Idaho, all board members unanimously voted to grant Unitek initial approval to plan a new nursing education program application for a Bachelor of Science in Nursing program, a Master’s Entry Program in Nursing, and a Practical Nursing program,” said Dr. Abdel Yosef, Chief Academic Officer at Unitek Learning. “The addition of these nursing programs will help alleviate nursing shortages in the state of Idaho.”

While the Idaho Board of Nursing has approved the development of these programs, they have not yet been approved by the school’s accrediting agency or the Idaho State Board of Education. Once finalized, students can benefit from a dynamic learning environment. This includes applied training, hands-on exercises, and clinical simulations. In addition, most students will benefit from class caps to maximize their learning experience. Some programs will also feature online coursework for the busy adult. Others will utilize state-of-the-art simulation centers with high-fidelity simulators and sim-view technology. The next generation can gain a well-rounded education at Unitek, effectively preparing them for successful health care careers.

“It has been another year of growth and opportunity for Unitek Learning, and we look forward to extending our reach in Idaho,” said David Higley, Chief Marketing Officer at Unitek Learning. “Through the Boise and Idaho Falls campuses, Unitek seeks to promote student excellence, strengthen support for workforce development, and help fill the need for health care professionals in the United States.”

Unitek Learning is the parent company of several distinguished learning institutions: Unitek College, Unitek EMT, Eagle Gate College, and Provo College. Unitek Learning is now expanding their presence to Idaho and Reno, Nevada. Taught by experienced professionals, Unitek programs teach clinical practices and theory used in the field today. Equipped with a multitude of sought-after skills, Unitek graduates are prepared to excel in many of the fastest-growing careers in health care and nursing.

Share article on social media or email:

“This designation recognizes Dr. Gregory McCoy as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
December 09, 2019

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Gregory McCoy, MD, The Oregon Clinic in Portland, OR has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Gregory McCoy has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Gregory McCoy as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

# # #

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Worldwide Business with kathy ireland® and PatentBooks™

Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with PatentBooks that will be airing in early 2020.

LOS ANGELES (PRWEB)
December 09, 2019

Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with PatentBooks that will be airing in early 2020.

PatentBooks is the world’s most efficient, economical, and inclusive patent licensing platform, enabling patent users to license all the patent rights needed for commercially significant products & services, and distributing patent royalties fairly and transparently to all patent owners.

The volume of patent licenses required for commercially significant products & services is so massive that the process of identifying and negotiating with each patent owner is impossible. Going to court, anywhere in the world, to seek payment from a patent user, is a fool’s game, only guaranteed to make lawyers wealthy. PatentBooks licensing simplifies patent licensing, is priced reasonably, transparent and uniformly available to all.

The Autonomous Vehicle PatentBook™ is available now. PatentBooks for Cloud Computing, Telemedicine, cancer cures, and solar & wind power will be available soon.

For more information about PatentBooks visit patentbooksinc.com.

About Worldwide Business with kathy ireland®

Worldwide Business with kathy ireland® is a weekly half-hour show featuring global executives sharing their business insights and framing the opportunities shaping their industries. Hosted by a business mogul, Kathy Ireland interviews some of the brightest minds in business today. The show broadcasts on Fox Business Network as part of their sponsored content line up and internationally on Bloomberg Television. Worldwide Business with kathy ireland® extends beyond the weekly on-air program with digital content delivered on various video platforms and across social media.

About PatentBooks, Inc. ™

PatentBooks, Inc. is the world’s most efficient, transparent, and fair patent licensing solution for both patent owners and users. PatentBooks, Inc. comes from miraculous insight, experience, and natural evolution of TAEUS Corporation, the world’s leading intellectual property consultancy, and TAEUSworks, the gold-standard of patent evaluations. Together PatentBooks, TAEUSworks, and TAEUS offer the world comprehensive solutions to transparently license all the patents needed to bring products to market, eliminating patent infringement lawsuits.

Share article on social media or email:

It is clear from his level of involvement in the field and multiple accreditations that Dr. Jenkins is committed to delivering the best care possible to his patients… That makes him an ideal representative of the CVR mission.

GREENBELT, Md. (PRWEB)
December 09, 2019

Center for Vein Restoration (CVR) is proud to announce the addition of Joseph Jenkins to its expanding and esteemed roster of physicians treating venous disease throughout the country. His practice in Dubuque is Center for Vein Restoration’s first location in Iowa. He is board certified in venous and lymphatic medicine and wound care, is the medical director of the Health Corp in Dubuque, Iowa, and is a diplomate of the American Board of Venous and Lymphatic Medicine. In 2011, he founded the Tri-State Vein Center, PC, an Intersocietal Accreditation Commission (IAC) accredited Vascular Testing and Vein Center.

Dr. Jenkins, a native of Dubuque, attended the University of Iowa, School of Medicine earning his MD in 1984. His first year of surgical training was completed at Walter Reed Army Medical Center, Washington, DC. For the next 3 years he was a general medical officer in Darmstadt, Germany. In 1988, he returned to the University of Iowa to complete a residency in general surgery. Dr. Jenkins spent the following year fulfilling his military obligation at Ft. Leonard Wood, MO. In July 1994, he returned to Dubuque and practiced as a general surgeon with Dubuque Surgery, PC. until December 31, 2010.

Dr. Jenkins opened the Tri-State Vein Center, PC, a practice dedicated to the treatment of patients with varicose veins and venous reflux. In 2017, Dr. Jenkins was certified as a Wound Specialist Physician by the American Board of Wound Management.

Dr. Sanjiv Lakhanpal, CEO; Dr. Khanh Q. Nguyen, Chief Medical Officer; Ken Abod, CFO; and Neil Collier, Chief Operating Officer, at CVR are all pleased to welcome Dr. Jenkins to the company. “It is clear from his level of involvement in the field and multiple accreditations that Dr. Jenkins is committed to delivering the best care possible to his patients,” added Dr. Lakhanpal. “That makes him an ideal representative of the CVR mission, ‘to improve lives in the communities we serve by providing state-of-the-art vascular care in a compassionate and affordable manner.’”

“I’m very excited to be joining an organization that will enable me to continue prioritizing patient satisfaction and high-quality care above all else,” noted Dr. Jenkins. “As a leader Dr. Lakhanpal understands the work that I have been doing for over thirty years, and with partnership and the resources provided by CVR I feel confident in advancing my efforts and dedicating even more time directly to patients’ needs.”

Dr. Jenkins has served thousands of patients throughout his career, and is regarded as experienced, friendly, and professional. Patients leave his office feeling relieved and confident and say they would recommend the treatment to a friend.

Dr. Jenkins’ accomplishments and accreditations also include:

• Member, Society of Diagnostic Medical Sonography
• Faculty Member, American Vein and Lymphatic Society
• Member, American Venous Forum

ABOUT VENOUS INSUFFICIENCY

Venous insufficiency, the cause of significant suffering due to the sequelae of venous hypertension, most commonly arises as achy, tired and heavy legs. It may or may not be associated with varicose veins, spider veins or skin changes including venous ulcerations and indiscriminately affects between 30–40 million Americans. Numerous factors including age, weight, prolonged sitting or standing, genetics or a history of DVT (blood clots) can increase the risk of developing this common and often underdiagnosed disorder. Treatment options have evolved to an array of minimally invasive procedures in an office setting.

ABOUT CENTER FOR VEIN RESTORATION

Center for Vein Restoration (CVR) is the largest physician-led practice treating vein disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 80 centers and growing, CVR has over 500 employees and conducts over 150,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.

Share article on social media or email:

Hep B Consult: A Point-of-Care Interactive Decision Support Tool

These data indicate that chronic hepatitis B is being mismanaged in a sizeable numbers of cases around the globe

RESTON, Va. (PRWEB)
December 09, 2019

Many healthcare providers showed discordance from guideline recommendations in their management plans for patients with chronic hepatitis B infection, according to an analysis of data from the “Hep B Consult,” a decision support tool developed by Clinical Care Options (CCO) this year.

“Hep B Consult” allows users to define a patient case scenario using variables, such as HBeAg status, HBV DNA and ALT levels, and liver histology, and receive instant recommendations from American, European, and Asian Pacific HBV guidelines.

Worldwide, users entered more than 8000 cases between March and October 2019. In 4130 of these cases, the guidelines had clear recommendations of whether to treat the patient’s HBV infection and with what to treat, yet in 43% of these cases, clinicians had a management plan that differed from the guidelines.

In 39% of such cases, clinicians indicated that they would change their treatment plan to match the guidelines after using the “Hep B Consult” tool.

“These data indicate that chronic hepatitis B is being mismanaged in a sizeable numbers of cases around the globe,” said Edward King, MA, Executive Vice President of CCO. “Moreover, using ‘Hep B Consult’ may enable clinicians to improve outcomes for people with chronic HBV infection by helping them make optimal treatment choices.”

The “Hep B Consult” app was developed by CCO in collaboration with the American Liver Foundation, the Asian Health Foundation, and Practicing Clinicians Exchange and is available as a Web-based tool and as apps for Android and Apple devices at:

Android: https://bit.ly/2VGZbxC

Apple: https://apple.co/2UVZrM4

Web: https://www.clinicaloptions.com/HBVIDST

These results were presented November 8 at The Liver Meeting 2019 in Boston, Massachusetts, and can be reviewed at https://www.clinicaloptions.com/CCO/Publications/2019/11_2019_HEP_B_Consult.

About Clinical Care Options

Clinical Care Options, LLC, is a global leader in the development of innovative educational programs and technology platforms. CCO’s team has been a pioneer in the creation of continuing education and decision support resources for healthcare professionals both in the United States and around the world for more than 2 decades. For more information, visit clinicaloptions.com.

Share article on social media or email: